Author Question: What body defense needs to be reduced in the patient following organ transplantation? A) Major ... (Read 60 times)

skymedlock · **on:** Jul 23, 2018

What body defense needs to be reduced in the patient following organ transplantation?

A) Major histocompatibility complex
B) Barrier defenses
C) Lymphoid tissues
D) Eosinophils

Question 2

When administering milrinone (Primacor), the nurse will assess the patient for what common adverse effect?

A) Hypoglycemia
B) Confusion
C) Hypotension
D) Seizures

Ahnyah · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
Feedback:
The major histocompatability complex is the genetic identification code carried on chromosomes and produces several proteins called histocompatibility antigens located on the cell membrane that allow the body to recognize cells that are self-cells. Cells without these proteins, such as those in a transplanted organ, are identified as foreign and are targeted for destruction so this defense must be minimized to prevent damage to the transplanted organ. Barrier defenses prevent entry of pathogens into the body. Lymphoid tissue creates cellular components of the mononuclear phagocyte system, differentiates T cells, and regulates actions of the immune system. Eosinophils respond to allergic responses. Barrier defenses, lymphoid tissue, and eosinophils are not involved in the transplant rejection process.

Answer to Question 2

C
Feedback:
The adverse effects most frequently seen with these drugs are ventricular arrhythmias (which can progress to fatal ventricular fibrillation), hypotension, and chest pain. Hypoglycemia, confusion, and seizures are not generally adverse effects of milrinone.